Found 41 hits of Enzyme Inhibition Constant Data Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338221
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)Nc2cccc(F)c2)c(Cl)c1 Show InChI InChI=1S/C19H16ClFN6O3/c1-29-25-9-14-17(22)23-10-24-18(14)30-13-5-6-16(15(20)8-13)27-19(28)26-12-4-2-3-11(21)7-12/h2-10H,1H3,(H2,22,23,24)(H2,26,27,28)/b25-9+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338215
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)Nc2cc(C)on2)c(Cl)c1 Show InChI InChI=1S/C17H16ClN7O4/c1-9-5-14(25-29-9)24-17(26)23-13-4-3-10(6-12(13)18)28-16-11(7-22-27-2)15(19)20-8-21-16/h3-8H,1-2H3,(H2,19,20,21)(H2,23,24,25,26)/b22-7+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338214
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)Nc2nc(C)c(C)s2)c(Cl)c1 Show InChI InChI=1S/C18H18ClN7O3S/c1-9-10(2)30-18(24-9)26-17(27)25-14-5-4-11(6-13(14)19)29-16-12(7-23-28-3)15(20)21-8-22-16/h4-8H,1-3H3,(H2,20,21,22)(H2,24,25,26,27)/b23-7+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338219
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)Nc2ccccc2OC)c(Cl)c1 Show InChI InChI=1S/C20H19ClN6O4/c1-29-17-6-4-3-5-16(17)27-20(28)26-15-8-7-12(9-14(15)21)31-19-13(10-25-30-2)18(22)23-11-24-19/h3-11H,1-2H3,(H2,22,23,24)(H2,26,27,28)/b25-10+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338217
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)Nc2ccccc2Cl)c(Cl)c1 Show InChI InChI=1S/C19H16Cl2N6O3/c1-29-25-9-12-17(22)23-10-24-18(12)30-11-6-7-16(14(21)8-11)27-19(28)26-15-5-3-2-4-13(15)20/h2-10H,1H3,(H2,22,23,24)(H2,26,27,28)/b25-9+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338222
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)Nc2ccc(F)cc2)c(Cl)c1 Show InChI InChI=1S/C19H16ClFN6O3/c1-29-25-9-14-17(22)23-10-24-18(14)30-13-6-7-16(15(20)8-13)27-19(28)26-12-4-2-11(21)3-5-12/h2-10H,1H3,(H2,22,23,24)(H2,26,27,28)/b25-9+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338216
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)Nc2ccccc2)c(Cl)c1 Show InChI InChI=1S/C19H17ClN6O3/c1-28-24-10-14-17(21)22-11-23-18(14)29-13-7-8-16(15(20)9-13)26-19(27)25-12-5-3-2-4-6-12/h2-11H,1H3,(H2,21,22,23)(H2,25,26,27)/b24-10+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338223
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)Nc2ccc(F)cc2F)c(Cl)c1 Show InChI InChI=1S/C19H15ClF2N6O3/c1-30-26-8-12-17(23)24-9-25-18(12)31-11-3-5-15(13(20)7-11)27-19(29)28-16-4-2-10(21)6-14(16)22/h2-9H,1H3,(H2,23,24,25)(H2,27,28,29)/b26-8+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338220
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)Nc2ccccc2F)c(Cl)c1 Show InChI InChI=1S/C19H16ClFN6O3/c1-29-25-9-12-17(22)23-10-24-18(12)30-11-6-7-15(13(20)8-11)26-19(28)27-16-5-3-2-4-14(16)21/h2-10H,1H3,(H2,22,23,24)(H2,26,27,28)/b25-9+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338213
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)Nc2nccs2)c(Cl)c1 Show InChI InChI=1S/C16H14ClN7O3S/c1-26-22-7-10-13(18)20-8-21-14(10)27-9-2-3-12(11(17)6-9)23-15(25)24-16-19-4-5-28-16/h2-8H,1H3,(H2,18,20,21)(H2,19,23,24,25)/b22-7+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 3.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338225
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)NC2CCCCC2)c(Cl)c1 Show InChI InChI=1S/C19H23ClN6O3/c1-28-24-10-14-17(21)22-11-23-18(14)29-13-7-8-16(15(20)9-13)26-19(27)25-12-5-3-2-4-6-12/h7-12H,2-6H2,1H3,(H2,21,22,23)(H2,25,26,27)/b24-10+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 6.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338218
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)Nc2ccccc2C)c(Cl)c1 Show InChI InChI=1S/C20H19ClN6O3/c1-12-5-3-4-6-16(12)26-20(28)27-17-8-7-13(9-15(17)21)30-19-14(10-25-29-2)18(22)23-11-24-19/h3-11H,1-2H3,(H2,22,23,24)(H2,26,27,28)/b25-10+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 7.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338224
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)NCc2ccc(F)cc2F)c(Cl)c1 Show InChI InChI=1S/C20H17ClF2N6O3/c1-31-28-9-14-18(24)26-10-27-19(14)32-13-4-5-17(15(21)7-13)29-20(30)25-8-11-2-3-12(22)6-16(11)23/h2-7,9-10H,8H2,1H3,(H2,24,26,27)(H2,25,29,30)/b28-9+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338211
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)Nc2cccnc2)c(Cl)c1 Show InChI InChI=1S/C18H16ClN7O3/c1-28-24-9-13-16(20)22-10-23-17(13)29-12-4-5-15(14(19)7-12)26-18(27)25-11-3-2-6-21-8-11/h2-10H,1H3,(H2,20,22,23)(H2,25,26,27)/b24-9+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338212
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)Nc2ccncc2)c(Cl)c1 Show InChI InChI=1S/C18H16ClN7O3/c1-28-24-9-13-16(20)22-10-23-17(13)29-12-2-3-15(14(19)8-12)26-18(27)25-11-4-6-21-7-5-11/h2-10H,1H3,(H2,20,22,23)(H2,21,25,26,27)/b24-9+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338201
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C15H17ClN6O3/c1-3-18-15(23)22-12-5-4-9(6-11(12)16)25-14-10(7-21-24-2)13(17)19-8-20-14/h4-8H,3H2,1-2H3,(H2,17,19,20)(H2,18,22,23)/b21-7+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338202
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C14H15ClN6O3/c1-17-14(22)21-11-4-3-8(5-10(11)15)24-13-9(6-20-23-2)12(16)18-7-19-13/h3-7H,1-2H3,(H2,16,18,19)(H2,17,21,22)/b20-6+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338203
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C16H19ClN6O3/c1-3-6-19-16(24)23-13-5-4-10(7-12(13)17)26-15-11(8-22-25-2)14(18)20-9-21-15/h4-5,7-9H,3,6H2,1-2H3,(H2,18,20,21)(H2,19,23,24)/b22-8+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338205
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)NC2CC2)c(Cl)c1 Show InChI InChI=1S/C16H17ClN6O3/c1-25-21-7-11-14(18)19-8-20-15(11)26-10-4-5-13(12(17)6-10)23-16(24)22-9-2-3-9/h4-9H,2-3H2,1H3,(H2,18,19,20)(H2,22,23,24)/b21-7+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338210
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)Nc2ccccn2)c(Cl)c1 Show InChI InChI=1S/C18H16ClN7O3/c1-28-24-9-12-16(20)22-10-23-17(12)29-11-5-6-14(13(19)8-11)25-18(27)26-15-4-2-3-7-21-15/h2-10H,1H3,(H2,20,22,23)(H2,21,25,26,27)/b24-9+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338204
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)NC(C)C)c(Cl)c1 Show InChI InChI=1S/C16H19ClN6O3/c1-9(2)22-16(24)23-13-5-4-10(6-12(13)17)26-15-11(7-21-25-3)14(18)19-8-20-15/h4-9H,1-3H3,(H2,18,19,20)(H2,22,23,24)/b21-7+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 73 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338234
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C15H18N6O3/c1-3-17-15(22)21-10-4-6-11(7-5-10)24-14-12(8-20-23-2)13(16)18-9-19-14/h4-9H,3H2,1-2H3,(H2,16,18,19)(H2,17,21,22)/b20-8+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 142 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338231
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C14H15FN6O3/c1-17-14(22)21-8-3-4-11(10(15)5-8)24-13-9(6-20-23-2)12(16)18-7-19-13/h3-7H,1-2H3,(H2,16,18,19)(H2,17,21,22)/b20-6+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 142 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338228
(CHEMBL1681958 | methyl 4-(6-amino-5-((methoxyimino...)Show InChI InChI=1S/C14H14ClN5O4/c1-22-14(21)20-8-3-4-11(10(15)5-8)24-13-9(6-19-23-2)12(16)17-7-18-13/h3-7H,1-2H3,(H,20,21)(H2,16,17,18)/b19-6+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 152 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338206
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)NCCO)c(Cl)c1 Show InChI InChI=1S/C15H17ClN6O4/c1-25-21-7-10-13(17)19-8-20-14(10)26-9-2-3-12(11(16)6-9)22-15(24)18-4-5-23/h2-3,6-8,23H,4-5H2,1H3,(H2,17,19,20)(H2,18,22,24)/b21-7+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 168 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338232
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C16H20N6O3/c1-4-18-16(23)22-11-5-6-13(10(2)7-11)25-15-12(8-21-24-3)14(17)19-9-20-15/h5-9H,4H2,1-3H3,(H2,17,19,20)(H2,18,22,23)/b21-8+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Proto-oncogene tyrosine-protein kinase receptor Ret
(Homo sapiens (Human)) | BDBM50338201
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C15H17ClN6O3/c1-3-18-15(23)22-12-5-4-9(6-11(12)16)25-14-10(7-21-24-2)13(17)19-8-20-14/h4-8H,3H2,1-2H3,(H2,17,19,20)(H2,18,22,23)/b21-7+ | PDB
MMDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 183 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of RET |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338208
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)NCCN(C)C)c(Cl)c1 Show InChI InChI=1S/C17H22ClN7O3/c1-25(2)7-6-20-17(26)24-14-5-4-11(8-13(14)18)28-16-12(9-23-27-3)15(19)21-10-22-16/h4-5,8-10H,6-7H2,1-3H3,(H2,19,21,22)(H2,20,24,26)/b23-9+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 285 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338207
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)NCCCO)c(Cl)c1 Show InChI InChI=1S/C16H19ClN6O4/c1-26-22-8-11-14(18)20-9-21-15(11)27-10-3-4-13(12(17)7-10)23-16(25)19-5-2-6-24/h3-4,7-9,24H,2,5-6H2,1H3,(H2,18,20,21)(H2,19,23,25)/b22-8+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Mast/stem cell growth factor receptor Kit
(Homo sapiens (Human)) | BDBM50338201
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C15H17ClN6O3/c1-3-18-15(23)22-12-5-4-9(6-11(12)16)25-14-10(7-21-24-2)13(17)19-8-20-14/h4-8H,3H2,1-2H3,(H2,17,19,20)(H2,18,22,23)/b21-7+ | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 513 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of KIT |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Macrophage colony-stimulating factor 1 receptor
(Homo sapiens (Human)) | BDBM50338201
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C15H17ClN6O3/c1-3-18-15(23)22-12-5-4-9(6-11(12)16)25-14-10(7-21-24-2)13(17)19-8-20-14/h4-8H,3H2,1-2H3,(H2,17,19,20)(H2,18,22,23)/b21-7+ | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 622 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of CSF1R |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338209
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show SMILES CO\N=C\c1c(N)ncnc1Oc1ccc(NC(=O)NCCCCN2CCCC2)c(Cl)c1 Show InChI InChI=1S/C21H28ClN7O3/c1-31-27-13-16-19(23)25-14-26-20(16)32-15-6-7-18(17(22)12-15)28-21(30)24-8-2-3-9-29-10-4-5-11-29/h6-7,12-14H,2-5,8-11H2,1H3,(H2,23,25,26)(H2,24,28,30)/b27-13+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 759 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 3
(Homo sapiens (Human)) | BDBM50338201
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C15H17ClN6O3/c1-3-18-15(23)22-12-5-4-9(6-11(12)16)25-14-10(7-21-24-2)13(17)19-8-20-14/h4-8H,3H2,1-2H3,(H2,17,19,20)(H2,18,22,23)/b21-7+ | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of FLT4 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Platelet-derived growth factor receptor alpha
(Homo sapiens (Human)) | BDBM50338201
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C15H17ClN6O3/c1-3-18-15(23)22-12-5-4-9(6-11(12)16)25-14-10(7-21-24-2)13(17)19-8-20-14/h4-8H,3H2,1-2H3,(H2,17,19,20)(H2,18,22,23)/b21-7+ | PDB
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of PDGFRalpha |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338226
(CHEMBL1681956 | N-(4-(6-amino-5-((methoxyimino)met...)Show InChI InChI=1S/C14H14ClN5O3/c1-8(21)20-9-3-4-12(11(15)5-9)23-14-10(6-19-22-2)13(16)17-7-18-14/h3-7H,1-2H3,(H,20,21)(H2,16,17,18)/b19-6+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.21E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 1
(Homo sapiens (Human)) | BDBM50338201
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C15H17ClN6O3/c1-3-18-15(23)22-12-5-4-9(6-11(12)16)25-14-10(7-21-24-2)13(17)19-8-20-14/h4-8H,3H2,1-2H3,(H2,17,19,20)(H2,18,22,23)/b21-7+ | PDB
MMDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 4.42E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of FLT1 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50338201
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C15H17ClN6O3/c1-3-18-15(23)22-12-5-4-9(6-11(12)16)25-14-10(7-21-24-2)13(17)19-8-20-14/h4-8H,3H2,1-2H3,(H2,17,19,20)(H2,18,22,23)/b21-7+ | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 4.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of FLT3 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338230
(2-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C15H17N5O3/c1-17-13(21)7-10-3-5-11(6-4-10)23-15-12(8-20-22-2)14(16)18-9-19-15/h3-6,8-9H,7H2,1-2H3,(H,17,21)(H2,16,18,19)/b20-8+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.97E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338233
(1-(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-...)Show InChI InChI=1S/C14H15BrN6O3/c1-17-14(22)21-8-3-4-11(10(15)5-8)24-13-9(6-20-23-2)12(16)18-7-19-13/h3-7H,1-2H3,(H2,16,18,19)(H2,17,21,22)/b20-6+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338229
(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-ylo...)Show InChI InChI=1S/C15H17N5O4/c1-3-17-15(21)24-11-6-4-10(5-7-11)23-14-12(8-20-22-2)13(16)18-9-19-14/h4-9H,3H2,1-2H3,(H,17,21)(H2,16,18,19)/b20-8+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50338227
(4-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-ylo...)Show InChI InChI=1S/C14H15N5O3/c1-16-13(20)9-3-5-10(6-4-9)22-14-11(7-19-21-2)12(15)17-8-18-14/h3-8H,1-2H3,(H,16,20)(H2,15,17,18)/b19-7+ | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development LLC
Curated by ChEMBL
| Assay Description
Inhibition of VEGFR2 |
Bioorg Med Chem Lett 21: 1815-8 (2011)
Article DOI: 10.1016/j.bmcl.2011.01.053
BindingDB Entry DOI: 10.7270/Q2ZP46DK |
More data for this
Ligand-Target Pair | |
Search and Browse
